These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12822385)

  • 21. The role of angiotensin receptor blockers in the management of chronic heart failure.
    Jamali AH; Tang WH; Khot UN; Fowler MB
    Arch Intern Med; 2001 Mar; 161(5):667-72. PubMed ID: 11231698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
    Gerc V; Buksa M
    Med Arh; 2010; 64(5):295-9. PubMed ID: 21287956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure.
    Campbell DJ; Aggarwal A; Esler M; Kaye D
    Lancet; 2001 Nov; 358(9293):1609-10. PubMed ID: 11716889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
    Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is there an indication for the association of betablockers and angiotensin II receptor antagonists in cardiac failure?].
    Jondeau G; Milleron O; Morisson-Castagnet JF
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):641-6. PubMed ID: 15283038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy.
    Dahlöf B
    J Hypertens Suppl; 1993 Apr; 11(3):S29-35. PubMed ID: 8315516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials of angiotensin receptor blockers in heart failure: what do we know and what will we learn?
    Pitt B
    Am J Hypertens; 2002 Jan; 15(1 Pt 2):22S-27S. PubMed ID: 11824872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B
    Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Angiotensin receptor antagonists and ACE inhibitors in heart failure: alternative or combined therapies?].
    Rapezzi C; Perugini E
    Monaldi Arch Chest Dis; 2002 May; 58(1):54-6. PubMed ID: 12693071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II receptor blockers in heart failure.
    Patterson JH
    Pharmacotherapy; 2003 Feb; 23(2):173-82. PubMed ID: 12587806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin receptor blockade with candesartan in heart failure: findings from the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programme.
    Ostergren JB
    J Hypertens Suppl; 2006 Mar; 24(1):S3-7. PubMed ID: 16601570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
    Schindler C
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):233-48. PubMed ID: 19124424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 40. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.